LU

Lundbeck A/S

- CPH:LUN
Last Updated 2024-05-02

Indeed Snapshot

Track Lundbeck A/S reviews on Indeed to uncover insights on employee sentiment

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Profile Url Name Website Industry Description Revenue Headquarters location CEO Rating: CEO (%) Rating: CEO Responses Count Rating: Overall Happiness: Compensation score Happiness: Support score Happiness: Purpose score Happiness: Flexibility score Happiness: Energy score Happiness: Work Happiness score Happiness: Trust score Happiness: Learning score Happiness: Belonging score Happiness: Inclusion score Happiness: Overall score Happiness: Appreciation score Happiness: Achievement score Happiness: Responses Count Review Count Ratings Responses Count Rating: Culture & Values Rating: Compensation & Benefits Rating: Job Security & Advancement Rating: Senior Management Rating: Worklife Balance Interview: Duration Responses count Interview Duration Interview: Difficulty Responses count Interview Difficulty Interview: Experience Responses count Interview Experience Work Culture: Stressful (0) to Relaxed (1) Ratio Work Culture: Slow Paced (0) to Fast Paced (1) Ratio Work Culture: Competitive (0) to Collaborative (1) Ratio Date Added Date Updated Company Name Sector Industry
cph:lun https://www.indeed.com/cmp/lundbeck Aug 29th, 2022 12:00AM Open LUNDBECK Pharmaceutical & Biotechnology Nearly 100 million Americans will suffer from a psychiatric or neurological disorder at some point in their lives. These are friends, family and neighbors wrestling with the debilitating symptoms of depression, talented young men and women dealing with lives torn at the seams by schizophrenia, and grandparents struggling to preserve their sense of self against the devastation of Alzheimer’s disease. At Lundbeck, we believe life is too beautiful to be interrupted by brain disorders. While brain research is complicated (the human brain is the most complex instrument in the known universe, containing nearly 100 billion neurons), risky (only 12 percent of molecules developed become approved therapies), and expensive (it takes a year longer to develop treatments for brain disorders than other pharmaceutical products and is half as likely to receive marketing approval, contributing to higher development costs), it is also essential. That’s why Lundbeck is the only global pharmaceutical company focused solely on the brain. Lundbeck is uncompromisingly committed to the research, development and delivery of targeted therapies for people living with significant psychiatric and neurological disorders. The people of Lundbeck believe these disorders can and must be cured, which is why we work every day toward bettering our knowledge of the brain, applying that knowledge to constantly improve therapies, and striving for a greater awareness of brain disorders and greater social acceptance of patients challenged by these conditions. Lundbeck has been engaged in brain disorder research and drug development for more than 70 years. During that time, we have brought breakthrough therapies to millions of people suffering from both psychiatric and neurological disorders. And we're just getting started. RRv1_1B_5B U.S. headquarters located in Deerfield, IL U.S. research hub in La Jolla, CA Seattle operations in Bothell, WA Global headquarters located in Valby, Denmark Dr. Deborah Dunsire, Chief Executive Officer 3.90 174.00 174.00 3.70 3.80 3.20 3.40 3.80 16.00 About a day or two 16.00 MEDIUM 16.00 FAVORABLE Aug 29th, 2022 05:32PM Aug 29th, 2022 05:32PM Lundbeck A/S Health Care Pharmaceuticals & Biotechnology
cph:lun https://www.indeed.com/cmp/alder-biopharmaceuticals Aug 29th, 2022 12:00AM Open Alder Biopharmaceuticals 4.20 5.00 5.00 4.30 4.20 3.40 3.50 5.00 Aug 29th, 2022 05:32PM Aug 29th, 2022 05:32PM Lundbeck A/S Health Care Pharmaceuticals & Biotechnology
cph:lun https://www.indeed.com/cmp/lundbeck Aug 28th, 2022 12:00AM Open LUNDBECK Pharmaceutical & Biotechnology Nearly 100 million Americans will suffer from a psychiatric or neurological disorder at some point in their lives. These are friends, family and neighbors wrestling with the debilitating symptoms of depression, talented young men and women dealing with lives torn at the seams by schizophrenia, and grandparents struggling to preserve their sense of self against the devastation of Alzheimer’s disease. At Lundbeck, we believe life is too beautiful to be interrupted by brain disorders. While brain research is complicated (the human brain is the most complex instrument in the known universe, containing nearly 100 billion neurons), risky (only 12 percent of molecules developed become approved therapies), and expensive (it takes a year longer to develop treatments for brain disorders than other pharmaceutical products and is half as likely to receive marketing approval, contributing to higher development costs), it is also essential. That’s why Lundbeck is the only global pharmaceutical company focused solely on the brain. Lundbeck is uncompromisingly committed to the research, development and delivery of targeted therapies for people living with significant psychiatric and neurological disorders. The people of Lundbeck believe these disorders can and must be cured, which is why we work every day toward bettering our knowledge of the brain, applying that knowledge to constantly improve therapies, and striving for a greater awareness of brain disorders and greater social acceptance of patients challenged by these conditions. Lundbeck has been engaged in brain disorder research and drug development for more than 70 years. During that time, we have brought breakthrough therapies to millions of people suffering from both psychiatric and neurological disorders. And we're just getting started. RRv1_1B_5B U.S. headquarters located in Deerfield, IL U.S. research hub in La Jolla, CA Seattle operations in Bothell, WA Global headquarters located in Valby, Denmark Dr. Deborah Dunsire, Chief Executive Officer 3.90 174.00 174.00 3.70 3.80 3.20 3.40 3.80 16.00 About a day or two 16.00 MEDIUM 16.00 FAVORABLE Aug 28th, 2022 12:31PM Aug 28th, 2022 12:31PM Lundbeck A/S Health Care Pharmaceuticals & Biotechnology
cph:lun https://www.indeed.com/cmp/alder-biopharmaceuticals Aug 28th, 2022 12:00AM Open Alder Biopharmaceuticals 4.20 5.00 5.00 4.30 4.20 3.40 3.50 5.00 Aug 28th, 2022 12:31PM Aug 28th, 2022 12:31PM Lundbeck A/S Health Care Pharmaceuticals & Biotechnology
cph:lun https://www.indeed.com/cmp/lundbeck Aug 27th, 2022 12:00AM Open LUNDBECK Pharmaceutical & Biotechnology Nearly 100 million Americans will suffer from a psychiatric or neurological disorder at some point in their lives. These are friends, family and neighbors wrestling with the debilitating symptoms of depression, talented young men and women dealing with lives torn at the seams by schizophrenia, and grandparents struggling to preserve their sense of self against the devastation of Alzheimer’s disease. At Lundbeck, we believe life is too beautiful to be interrupted by brain disorders. While brain research is complicated (the human brain is the most complex instrument in the known universe, containing nearly 100 billion neurons), risky (only 12 percent of molecules developed become approved therapies), and expensive (it takes a year longer to develop treatments for brain disorders than other pharmaceutical products and is half as likely to receive marketing approval, contributing to higher development costs), it is also essential. That’s why Lundbeck is the only global pharmaceutical company focused solely on the brain. Lundbeck is uncompromisingly committed to the research, development and delivery of targeted therapies for people living with significant psychiatric and neurological disorders. The people of Lundbeck believe these disorders can and must be cured, which is why we work every day toward bettering our knowledge of the brain, applying that knowledge to constantly improve therapies, and striving for a greater awareness of brain disorders and greater social acceptance of patients challenged by these conditions. Lundbeck has been engaged in brain disorder research and drug development for more than 70 years. During that time, we have brought breakthrough therapies to millions of people suffering from both psychiatric and neurological disorders. And we're just getting started. RRv1_1B_5B U.S. headquarters located in Deerfield, IL U.S. research hub in La Jolla, CA Seattle operations in Bothell, WA Global headquarters located in Valby, Denmark Dr. Deborah Dunsire, Chief Executive Officer 3.90 174.00 174.00 3.70 3.80 3.20 3.40 3.80 16.00 About a day or two 16.00 MEDIUM 16.00 FAVORABLE Aug 27th, 2022 10:08AM Aug 27th, 2022 10:08AM Lundbeck A/S Health Care Pharmaceuticals & Biotechnology
cph:lun https://www.indeed.com/cmp/alder-biopharmaceuticals Aug 27th, 2022 12:00AM Open Alder Biopharmaceuticals 4.20 5.00 5.00 4.30 4.20 3.40 3.50 5.00 Aug 27th, 2022 10:08AM Aug 27th, 2022 10:08AM Lundbeck A/S Health Care Pharmaceuticals & Biotechnology
cph:lun https://www.indeed.com/cmp/alder-biopharmaceuticals Aug 25th, 2022 12:00AM Open Alder Biopharmaceuticals 4.20 5.00 5.00 4.30 4.20 3.40 3.50 5.00 Aug 25th, 2022 02:32PM Aug 25th, 2022 02:32PM Lundbeck A/S Health Care Pharmaceuticals & Biotechnology
cph:lun https://www.indeed.com/cmp/lundbeck Aug 25th, 2022 12:00AM Open LUNDBECK Pharmaceutical & Biotechnology Nearly 100 million Americans will suffer from a psychiatric or neurological disorder at some point in their lives. These are friends, family and neighbors wrestling with the debilitating symptoms of depression, talented young men and women dealing with lives torn at the seams by schizophrenia, and grandparents struggling to preserve their sense of self against the devastation of Alzheimer’s disease. At Lundbeck, we believe life is too beautiful to be interrupted by brain disorders. While brain research is complicated (the human brain is the most complex instrument in the known universe, containing nearly 100 billion neurons), risky (only 12 percent of molecules developed become approved therapies), and expensive (it takes a year longer to develop treatments for brain disorders than other pharmaceutical products and is half as likely to receive marketing approval, contributing to higher development costs), it is also essential. That’s why Lundbeck is the only global pharmaceutical company focused solely on the brain. Lundbeck is uncompromisingly committed to the research, development and delivery of targeted therapies for people living with significant psychiatric and neurological disorders. The people of Lundbeck believe these disorders can and must be cured, which is why we work every day toward bettering our knowledge of the brain, applying that knowledge to constantly improve therapies, and striving for a greater awareness of brain disorders and greater social acceptance of patients challenged by these conditions. Lundbeck has been engaged in brain disorder research and drug development for more than 70 years. During that time, we have brought breakthrough therapies to millions of people suffering from both psychiatric and neurological disorders. And we're just getting started. RRv1_1B_5B U.S. headquarters located in Deerfield, IL U.S. research hub in La Jolla, CA Seattle operations in Bothell, WA Global headquarters located in Valby, Denmark Dr. Deborah Dunsire, Chief Executive Officer 3.90 174.00 174.00 3.70 3.80 3.20 3.40 3.80 16.00 About a day or two 16.00 MEDIUM 16.00 FAVORABLE Aug 25th, 2022 02:32PM Aug 25th, 2022 02:32PM Lundbeck A/S Health Care Pharmaceuticals & Biotechnology
cph:lun https://www.indeed.com/cmp/alder-biopharmaceuticals Aug 23rd, 2022 12:00AM Open Alder Biopharmaceuticals 4.20 5.00 5.00 4.30 4.20 3.40 3.50 5.00 Aug 23rd, 2022 04:19PM Aug 23rd, 2022 04:19PM Lundbeck A/S Health Care Pharmaceuticals & Biotechnology
cph:lun https://www.indeed.com/cmp/lundbeck Aug 23rd, 2022 12:00AM Open LUNDBECK Pharmaceutical & Biotechnology Nearly 100 million Americans will suffer from a psychiatric or neurological disorder at some point in their lives. These are friends, family and neighbors wrestling with the debilitating symptoms of depression, talented young men and women dealing with lives torn at the seams by schizophrenia, and grandparents struggling to preserve their sense of self against the devastation of Alzheimer’s disease. At Lundbeck, we believe life is too beautiful to be interrupted by brain disorders. While brain research is complicated (the human brain is the most complex instrument in the known universe, containing nearly 100 billion neurons), risky (only 12 percent of molecules developed become approved therapies), and expensive (it takes a year longer to develop treatments for brain disorders than other pharmaceutical products and is half as likely to receive marketing approval, contributing to higher development costs), it is also essential. That’s why Lundbeck is the only global pharmaceutical company focused solely on the brain. Lundbeck is uncompromisingly committed to the research, development and delivery of targeted therapies for people living with significant psychiatric and neurological disorders. The people of Lundbeck believe these disorders can and must be cured, which is why we work every day toward bettering our knowledge of the brain, applying that knowledge to constantly improve therapies, and striving for a greater awareness of brain disorders and greater social acceptance of patients challenged by these conditions. Lundbeck has been engaged in brain disorder research and drug development for more than 70 years. During that time, we have brought breakthrough therapies to millions of people suffering from both psychiatric and neurological disorders. And we're just getting started. RRv1_1B_5B U.S. headquarters located in Deerfield, IL U.S. research hub in La Jolla, CA Seattle operations in Bothell, WA Global headquarters located in Valby, Denmark Dr. Deborah Dunsire, Chief Executive Officer 3.90 174.00 174.00 3.70 3.80 3.20 3.40 3.80 16.00 About a day or two 16.00 MEDIUM 16.00 FAVORABLE Aug 23rd, 2022 04:19PM Aug 23rd, 2022 04:19PM Lundbeck A/S Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.